What is a cash flow statement?

A cash flow statement tracks the actual cash moving in and out of a company during a period. It's divided into three sections: operating activities (core business), investing activities (assets and investments), and financing activities (debt and equity). Unlike the income statement, it shows real cash rather than accounting profits.

What is operating cash flow?

Operating cash flow is the cash generated from a company's core business operations. It adjusts net income for non-cash items like depreciation and changes in working capital. Strong operating cash flow indicates the business can fund operations without external financing.

What is free cash flow (FCF)?

Free cash flow is operating cash flow minus capital expenditures. It represents the cash available for dividends, share buybacks, debt repayment, or reinvestment. FCF is considered one of the most important metrics for evaluating a company's financial health.

What are capital expenditures?

Capital expenditures (CapEx) are funds spent on acquiring or maintaining physical assets like property, equipment, and technology. CapEx appears in the investing activities section and is subtracted from operating cash flow to calculate free cash flow.

How is HAE's cash generation trending?

Review Haemonetics's operating cash flow and free cash flow figures in the quarterly and annual data above. Consistent growth in operating cash flow relative to net income indicates high-quality earnings.

Haemonetics (HAE) Cash Flow: Operating & Free Cash Flow

Haemonetics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Haemonetics Corporation (HAE) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 2026	Mar 2025	Mar 2024	Apr 2023	Mar 2023	Apr 2022	Mar 2022	Apr 2021	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Operating Activities
Net Income	97.31	167.68	117.56	115.40	115.40	43.38	43.38	79.47	79.47	76.53	55.02	45.57	-26.27
Depreciation & Amortization	111.72	115.59	97.22	93.31	93.31	97.75	97.75	84.29	84.29	110.29	109.42	89.25	89.73
Deferred Income Tax	-0.71	-5.22	-11.04	0.00	4.78	0.00	5.01	0.00	-19.87	-6.96	13.35	-5.83	-6.80
Stock Based Compensation	33.83	29.64	28.33	25.58	25.58	24.36	24.36	25.52	25.52	20.45	17.19	13.03	9.15
Change in Working Capital	-23.65	-101.96	-74.70	25.50	25.50	-15.18	-15.18	-59.68	-59.68	-84.56	-62.75	76.49	-0.98
Change in Accounts Receivable	-14.88	6.96	-24.19	-24.42	-24.42	-34.97	-34.97	44.12	44.12	18.86	-38.06	5.09	3.16
Change in Inventory	47.36	-64.70	-60.06	30.75	30.75	24.31	24.31	-38.91	-38.91	-84.72	-39.32	14.39	-1.55
Change in Accounts Payable	-16.57	-19.21	44.58	39.82	39.82	7.64	0.00	-56.42	-56.42	-17.31	17.74	41.40	21.07
Change in Other Working Capital	-39.56	-44.21	14.98	-22.33	-20.65	-15.02	19.46	-4.65	-64.89	-1.40	-3.10	57.02	-2.59
Other Operating Activities	74.74	-24.00	14.98	13.26	8.48	21.96	19.46	-20.79	-0.92	42.47	27.06	1.85	94.91
Net Cash from Operating Activities	293.22	181.73	181.75	273.06	273.06	172.26	172.26	108.81	108.81	158.22	159.28	220.35	159.74
Investing Activities
Capital Expenditures	-32.78	-39.28	-38.13	-191.33	-110.19	-96.51	-96.51	-37.04	-37.04	-48.76	-118.96	-74.80	-76.14
Acquisitions	1.38	-107.62	-243.85	-2.85	-2.00	-2.50	-2.50	-434.80	-390.22	-25.19	2.81	9.00	2.82
Purchases of Investments	0.00	0.00	-15.55	-33.21	-33.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Investing Activities	-87.96	-15.00	-41.91	47.93	1.61	51.80	2.02	9.29	1.82	16.77	2.81	2.76	2.82
Net Cash from Investing Activities	-179.55	-161.90	-322.39	-143.79	-143.79	-86.35	-86.35	-425.44	-425.44	-57.18	-116.15	-63.04	-73.31
Financing Activities
Debt Repayment	-6.25	447.31	-72.25	-339.63	-9.63	-17.50	-17.50	-21.88	418.13	31.88	95.93	-60.98	-93.41
Common Stock Issued	7.89	0.00	7.21	7.02	0.00	6.55	0.00	10.23	0.00	0.00	0.00	0.00	0.00
Common Stock Repurchased	-175.00	-225.00	0.00	-75.00	-75.00	0.00	0.00	0.00	0.00	-175.00	-160.00	-100.00	0.00
Other Financing Activities	-5.10	-113.49	-0.92	-22.76	-15.74	-4.80	-4.80	-60.90	-50.67	11.92	13.45	40.34	0.00
Net Cash from Financing Activities	-178.46	108.82	38.16	-100.36	-100.36	-15.75	-15.75	367.45	367.45	-131.21	-50.63	-120.64	-60.41
Summary
Effect of Forex Changes on Cash	3.46	-0.69	-3.19	-3.94	-3.94	-2.98	-2.98	4.18	4.18	-1.87	-3.32	3.94	-1.57
Net Change in Cash	-61.32	127.96	-105.67	24.97	24.97	67.19	67.19	54.99	54.99	-32.04	-10.82	40.61	24.44
Cash at Beginning of Period	306.76	178.80	284.47	0.00	259.50	0.00	192.31	0.00	137.31	169.35	180.17	139.56	115.12
Cash at End of Period	245.44	306.76	178.80	0.00	284.47	0.00	259.50	0.00	192.31	137.31	169.35	180.17	139.56
Free Cash Flow	260.44	142.45	143.63	81.73	162.87	75.75	75.75	71.77	71.77	109.46	40.32	145.55	83.60
Supplemental Disclosures
Interest Paid	0.00	16.53	20.90	13.59	0.00	6.19	0.00	7.82	0.00	0.00	0.00	0.00	0.00
Income Taxes Paid	0.00	49.29	52.71	17.97	0.00	24.30	0.00	12.49	0.00	0.00	0.00	0.00	0.00

Haemonetics (HAE) Cash Flow Statement

Haemonetics Cash Flow Statement Analysis

Frequently Asked Questions About Haemonetics Cash Flow

Free Cash Flow (FCF)

FCF Per Share

Cash Flow to Debt

Dividend Payout Ratio

EBITDA

Return on Invested Capital (ROIC)

Haemonetics Cash Flow Statement Analysis

Frequently Asked Questions About Haemonetics Cash Flow

Metrics Derived from the Cash Flow Statement

Free Cash Flow (FCF)

FCF Per Share

Cash Flow to Debt

Dividend Payout Ratio

EBITDA

Return on Invested Capital (ROIC)